Balchem (BCPC) Q3 FY26 earnings call

Balchem delivered a record third quarter, fueled by healthy, broad-based growth across all segments, driven by market penetration of specialty nutrients and favorable "better-for-you" trends. The company continues to leverage its scientific foundation for branded ingredients and strategic capital allocation, including share repurchases and capacity expansion, while navigating inflationary pressures and geopolitical risks. Management remains optimistic about the outlook, expecting continued year-over-year growth in the fourth quarter.